Abstract

‘Treat-to-target’ paradigms in Crohn’s disease (CD) directed at suppressing intestinal inflammation require accurate and reliable measures of disease activity.

Tags

Biomarker, C-Reactive Protein, Crohn's Disease, Diagnosis, Endoscopy, fecal calprotectin, Immunology, Inflammation Mediators, Leukocyte L1 Antigen Complex, Mucosal Healing, Prognosis, Therapy, Treat-to-Target

Read More